Skip to search formSkip to main contentSkip to account menu

Percent Free Prostate-Specific Antigen Measurement

Known as: Free Prostate-Specific Antigen, Percent Free Prostate-Specific Antigen, free PSA 
The amount of the protein prostate-specific antigen (PSA) in the blood that is not attached to other proteins. It is compared with the amount of PSA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Performance of serum prostate‐specific antigen isoform [‐2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital‐based biopsy population
The use of serum [‐2]proPSA (p2PSA) and its derivative, the prostate health index (PHI), in detecting prostate cancer (PCa) have… 
Highly Cited
2009
Highly Cited
2009
A [‐2]proPSA‐based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases
The aim of this study was to combine the new automated Access [‐2]proPSA (p2PSA) assay with a percent free PSA (%fPSA) based… 
2008
2008
Prostate-specific antigen in the serum of women with benign breast disease.
2008
2008
Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional…
Abstract Background: The metrological traceability of prostate-specific antigen (PSA) assay calibration to WHO standards is… 
Highly Cited
2007
Highly Cited
2007
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
Clinicians currently use simple cut‐points, such as serum prostate‐specific antigen (PSA) ≥≥4 ng/ml, to decide whether to… 
2004
2004
Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA)
Recent studies have reported enhanced prostate cancer detection in Caucasians with serum human glandular kallikrein 2 (hK2) in… 
2004
2004
Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?
BACKGROUND The combined use of free and total prostate-specific antigen (PSA) in early detection of prostate cancer has been… 
2001
2001
Diagnostic Accuracy of Percent Free Prostate-Specific Antigen in Prostatic Pathology and Its Usefulness in Monitoring Prostatic Cancer Patients
Introduction: The aim of our study was to evaluate the clinical usefulness of percent free prostate-specific antigen (PSA) [ratio… 
1999
1999
Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free…
Highly Cited
1997
Highly Cited
1997
Factors influencing the ratio of free to total prostate‐specific antigen in serum
The ratio of free prostate‐specific antigen (f‐PSA) to total PSA (t‐PSA) in serum, calculated as percent free PSA (f‐PSA%), is… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)